[Immunopathological factors influencing the prognosis after resection of lung cancer].
118 surgical specimens were obtained from patients with lung cancer treated in our hospital during the period of 1977-1983 and tested with carcinoembryonic antigen (CEA), ABO (H) isoantigen and Concanavalin A (ConA). The results showed that the CEA assessment, which give no prognostic significance for long-term survival (P greater than 0.05), would be useful in predicting short-term (6 month) out come (P less than 0.05). All patients with positive ABO (H) test for squamous cell lung carcinoma survived at the end of five years. As for ConA, no definite link has been found with the prognosis.
Zhang
Y F
YF
Qingdao Medical College.
D000017:ABO Blood-Group System / Q000276:immunology; D000230:Adenocarcinoma / Q000276:immunology / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000601:surgery; D003208:Concanavalin A / Q000032:analysis; D006801:Humans; D007519:Isoantigens / Q000032:analysis*; D008175:Lung Neoplasms / Q000276:immunology* / Q000601:surgery; D011379:Prognosis
D000017:ABO Blood-Group System; D002272:Carcinoembryonic Antigen; D007519:Isoantigens; D003208:Concanavalin A